Skip to content

Impacts of Neoadjuvant therapy on Survival and Recurrence Patterns in High-Risk Resectable Intrahepatic Cholangiocarcinoma: A propensity Score Analysis

Impacts of Neoadjuvant therapy on Survival and Recurrence Patterns in High-Risk Resectable Intrahepatic Cholangiocarcinoma: A propensity Score Analysis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600127258
Enrollment
Unknown
Registered
2026-06-28
Start date
2026-06-29
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intrahepatic cholangiocarcinoma

Interventions

Observation group:None

Sponsors

Sun Yat-sen Memorial Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age 18 to 80 years; 2. Pathological diagnosis of ICC; 3. Performance status of 0 or 1 at diagnosis; 4. Child-Pugh class A or B; 5. Availability of magnetic resonance imaging (MRI) or contrast-enhanced computed tomography (CE-CT) within two months prior to NAT; 6. At least one measurable target lesion according to Response Evaluation Criteria in Solid Tumors (RECIST) as well as modified Response Evaluation Criteria in Solid Tumors (mRECIST); 7. Curative resection, defined as complete removal of all lesions with margin-negative (R0) or microscopically positive (R1) resection margins; 8. high-risk resectable ICC;

Exclusion criteria

Exclusion criteria: 1. Initial unresectability or palliative surgery; 2. American Joint Committee on Cancer (AJCC) 8th edition TNM stage IA; 3. Macroscopically positive (R2) resection; 4. Resection for recurrent disease; 5. Other concurrent malignancies; 6. Missing clinicopathological data; 7. Loss to follow-up;

Design outcomes

Primary

MeasureTime frame
Disease-free survival;

Secondary

MeasureTime frame
Textbook outcome;Overall survival;

Countries

China

Contacts

Public ContactChangzhen Shang

Sun Yat-sen Memorial Hospital

shchzh2@mail.sysu.edu.cn+86 20 34070701

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 3, 2026